Formulation and evaluation of microsphere based Oro dispersible tablets of itopride HCL

DARU, Journal of Pharmaceutical Sciences

Volumn 20, Issue 1, 2012, Pages

  Shah, Sanjay ^a   Madan, Sarika ^a   Agrawal, S S ^a  

^a DELHI INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

Author keywords

Eudragit EPO; Itopride HCL; Orodispersible tablets; Superdisintegrants; Taste masking

Indexed keywords

ACETONE; DILUENT; EUDRAGIT; EXCIPIENT; ITOPRIDE; LIQUID PARAFFIN; MICROSPHERE; POLYMER; SOLVENT; SWEETENING AGENT;

ARTICLE; BIOEQUIVALENCE; BITTER TASTE; DISPERSIBLE TABLET; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; ENCAPSULATION; EVAPORATION; FLAVOR; IN VITRO STUDY; NONHUMAN; ORO DISPERSIBLE TABLET; PARTICLE SIZE; PH; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET THICKNESS; THERMAL ANALYSIS;

EID: 84888200407     PISSN: 15608115     EISSN: 20082231     Source Type: Journal    
DOI: 10.1186/2008-2231-20-24     Document Type: Article

References (35)

1. Kuchekar BS, Badhan AC, Mahajan HS: Mouth dissolving tablets of salbutamol sulphate: A novel drug delivery system. Indian Drugs 2004, 41:592-598.
2. Hoogstrate AJ, Verhoef JC, Tuk B, Pijpers A: In-vivo buccal delivery of fluorescin isothiocyanate-dextran 4400 with glycodeoxycholate as an absorption enhancer in pig. J Pharm Sci 1996, 85:457-460.
3. USFDA, "Inactive Ingredient Search for Approved Drug Products, " Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Rockville, MD. 2009. http://www.accessdata.fda.gov/scripts/cder/iig/ index.cfm.
4. Roy GM: Taste masking in oral pharmaceuticals. Pharm. Tech 1994, 18:85-91.
5. Nanda A, Kandarapu R, Garg S: An update on oral taste masking technologies for oral pharmaceuticals. Indian J. Pharm. Sci 2002, 64:10-17.
6. Anand V, Raghupathi K, Garg S: Ion-Exchange resins: carrying drug delivery forward. Drug Discovery Today 2001, 6:905-914. (Pubitemid 32750631)
7. Bodmeier R, Chen H, Tyle P, Jarosz P: Pseudoephedrine HCl microspheres formulated into an oral suspension dosage form. J. Control. Release 1991, 8:65-77.
8. Bogataj M, Mrhar A, Kristl A, Kozjek F: Eudragit E microspheres containing bacampicillin: preparation by solvent removal methods. J Microencapsul 1991, 8:401-406.
9. Goto S, Kawata M, Nakamura M, Maekawa K, Aoyoma T: Eudragit RS and RL (acrylic resins) microcapsules as pH insensitive and sustained release preparations of ketoprofen. J Microencapsul 1986, 3:293-304. (Pubitemid 17220750)
10. Lorenzo-Lamosa ML, Cuna M, Vila-Jato JL, Torres D, Alonso MJ: Development of a microencapsulated form of cefuroxime axetil using pH-sensitive acrylic polymers. J Microencapsul 1997, 14:607-616. (Pubitemid 27380192)
11. Pignatello R, Consoli P, Puglisi G: In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles. J Microencapsul 2000, 17:373-383. (Pubitemid 30235009)
12. Bogataj M, Mrhar A, Kristl A, Kozjek F: Preparation and evaluation of Eudragit E microspheres containing bacampicillin. Drug Dev. Ind. Pharm 1991, 15:2295-2313. (Pubitemid 20027595)
13. Gupta S, Kapoor V, Kapoor B: Itopride a novel prokinetic agent. J?K Science Drug Review 2004, 6(2):106-108.
14. United States Pharmacopeia XXXII. Rockville (MD): National Formulary XXVII, USP Convention; 2009.
15. Lachman L, Liberman HA, Kanig JL: The theory and practice of industrial pharmacy. 3rd edition. Mumbai: Varghese Publishing House; 1991:209-303.
16. Lachman L, Liberman HA, Kanig JL: The theory and practice of industrial Pharmacy. 3rd edition. Mumbai: Varghese publishing house; 1987:184.
17. Levis SR, Deasy PB: Pharmaceutical applications of size reduced grades of surfactant co-processed micro crystalline cellulose. Int J Pharm 2001, 230:25-33. (Pubitemid 32973856)
18. SIEVE-CONVERSION-CHART.pdf. Accessed on; 2011. http://www.qclabequipment. com/.
19. Gao Y, Cui FD, Guan Y, Yang L, Wang YS, Zhang LN: Preparation of roxithromycin-polymeric microspheres by the emulsion solvent diffusion method for taste masking. Int J Pharm 2006, 318:62-69. (Pubitemid 43983049)
20. Ringard J, Guyot-Hermann AM. Calculation of disintegrant critical concentration in order to optimize tablets disintegration. Drug Dev. Ind. Pharm 1988, 14(15-17):1321-2339.
21. Marshall K, Lachman L, Lieberman HA, Kanig JL (Eds): The theory and practice of industrial Pharmacy. 3rd edition. Mumbai: Varghese publishing house; 1987.
22. Indian Pharmacopoeia. VIth edth edition. Delhi: Government of India, Ministry of Health and Family Welfare; 2010:1681-1683.
23. Zhao N, Augsburger LL. Functionality comparison of three classes of super disintegrants in promoting aspirin tablets disintegration and dissolution. AAPS PharmSci. Tech 2005, 6(4):634-40.
24. Bi Y: Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem Pharm Bull 1996, 44:2121-2127. (Pubitemid 26396765)
25. Amin AF, Shah TJ, Bhadani MN, Patel MM: Emerging trends in the development of orally disintegrating tablet technology; 2011. http://www.pharmainfo.net Accessed 6 April 2011.
26. Swamy PV, Shahidulla SM, Shirsand SB, Hiremath SN, Ali MY: Orodispersible tablets of carbmszepine prepared by direct compression method using 32 full factorial designs. J Pharm Sci 2008, 7:1-5.
27. Klancke J: Dissolution testing of orally disintegrating tablets. Dissolution Technologies 2003, 6:6-8.
28. Kulkarni GT, Subburaju T: Stability testing of pharmaceutical products: An over- View. Ind. J. Pharm. Educ 2004, 38(4):24-30.
29. Xu J, Bovet LL, Zhao K: In situ gelling hydrogels for pharmaceutical and biomedical application. Int J Pharm 2008, 359:63-69.
30. Hunter E, Fell JT, Sharma H: The gastric emptying of pellets contained in hard gelatin capsules. Drug Dev. Ind. Pharm 1982, 8:751-757. (Pubitemid 12068919)
31. Dooran AAV: Design of drug excipient interaction study. Drug Dev. Ind. Pharm 1983, 9:43-45.
32. Patel DM, Patel NM, Shah RR, Jogani PL, Balapatel AI: Studies in formulation of orodispersible tablets of rofecoxib. Indian J. Pharm. Sci 2004, 66:621-625.
33. Kaushik D, Dureja H, Saini TR: Formulation and evaluation of Olanzapine mouth dissolving tablets by effervescent formulation approach. Indian Drugs 2004, 41(7):410-2.
34. European Pharmacopoeia. 5, Vol Ith edition. Great Britain: Directorate of Medicine and Health; 2005, 628-629.
35. Khan S, Kataria P, Nakhat P, Yeole P: Taste Masking of Ondansetron Hydrochloride by Polymer Carrier System and Formulation of Rapid- Disintegrating Tablets. AAPS PharmSci. Tech 2007, 8:E1-E7.